Table of Contents
Overview
Definition and Importance
Proteomics is the study of the proteome, which includes the complete set of proteins produced in a biological system. This field aims to understand proteins in terms of their structures, interactions, functions, and expression levels across various biological contexts.[2.1] Key methodologies in proteomics involve sample preparation, protein separation, identification, and validation. Sample preparation is crucial as it involves extracting and purifying proteins from biological samples for analysis.[2.1] The significance of proteomics lies in its ability to generate comprehensive datasets that elucidate protein expression dynamics across different tissues and cell types, which is vital for understanding the molecular underpinnings of biological processes and diseases.[4.1] Proteomics has broad applications, including drug discovery, where it aids in identifying potential drug targets and evaluating the efficacy of therapeutic interventions.[6.1] Additionally, it plays a pivotal role in biomarker identification, essential for diagnosing and prognosing various conditions, such as glioblastoma.[6.1] By integrating proteomics data with genomics and transcriptomics, researchers can enhance patient-specific management strategies, thereby adding a critical dimension to _personalized medicine.[6.1]Applications in Biomedical Research
Advancements in proteomic technologies have significantly enhanced biomedical research, particularly in the realm of personalized medicine. The integration of proteomics with other omics technologies, such as genomics and metabolomics, has facilitated a deeper understanding of complex diseases and improved personalized treatment strategies. For instance, machine learning has been employed to build predictive models that analyze combinations of genetic variants, proteins, and metabolites, leading to the identification of potential biomarkers for various complex diseases.[9.1] This multi-omics approach allows for a systematic prioritization of biomarkers, which is crucial for advancing personalized medicine.[10.1] Proteomics plays a vital role in the detection of protein biomarkers, which are essential for developing proteomics-based molecular diagnostics and pharmacoproteomics.[7.1] The ability to profile proteins on a global scale provides valuable insights into disease mechanisms and treatment efficacy. For example, the drug agency MLWH in Japan has emphasized the importance of linking treatment data for lung cancer patients to optimal efficacy and safety, showcasing how proteomics can inform drug development and patient care.[8.1] Recent advancements in mass spectrometry (MS)-based proteomics have further transformed pathology research and diagnostics. These advancements enable comprehensive studies of protein expression and post-translational modifications, which are critical for understanding disease mechanisms.[11.1] Techniques such as affinity purification, proximity labeling, and cross-linking have enhanced the study of protein-protein interactions (PPIs), which are crucial for various biological processes and are often disrupted in diseases like cancer and neurodegeneration.[15.1] The integration of these methods with computational tools has improved the elucidation of complex cellular networks, thereby enhancing our understanding of disease mechanisms.[13.1] Moreover, the development of high-resolution mass spectrometry combined with AI-driven image analysis allows for exceptional spatial resolution in mapping protein expression patterns within complex tissues.[14.1] This capability is particularly valuable for functional studies in proteomics, as it enables researchers to investigate the spatial dynamics of proteins in relation to disease states.History
Early Developments in Proteomics
The early developments in proteomics can be traced back nearly 50 years, although the term "proteome" was not coined until 1994 by a team of researchers led by Marc Wilkins, who was then a doctoral student attending a 2D electrophoresis conference.[43.1] This period marked the beginning of a systematic approach to studying proteins, focusing on their expression levels and post-translational modifications, particularly in relation to diseases.[40.1] As the field evolved, researchers began to recognize the importance of proteomics as an extrapolation of the genome project, aiming to identify and characterize the proteins present in cells or tissues and define their expression patterns.[76.1] This shift in focus from genomics to proteomics was significant, as it allowed for a more comprehensive understanding of biological processes and disease mechanisms. In the early stages, large-scale shotgun proteomics analyses faced challenges, including considerable variability between laboratories due to technical differences. However, advancements in mass spectrometry techniques improved reproducibility, particularly at the protein level.[42.1] The introduction of targeted proteomics further enhanced the reliability of results, although it came at the cost of data density compared to shotgun methods.[42.1] The year 2014 was particularly notable as it marked the 20th anniversary of the term proteomics, prompting a reflection on the significant advances made in the field over two decades. These advancements have catalyzed the capacity to address experimental, translational, and clinical implications of proteomics, especially in areas such as cardiovascular health and disease.[79.1]Milestones in Technological Advancements
The evolution of proteomics has been significantly shaped by advancements in mass spectrometry (MS) and bioinformatics tools, which have collectively enhanced the sensitivity and accuracy of protein identification and quantification. Over the past two decades, mass spectrometry has emerged as the primary method for protein identification from complex biological mixtures, largely due to instrumental advancements that enable the routine analysis of minute amounts of peptides, typically in the femtomole range.[56.1] This capability has been further enhanced by improved sample simplification procedures, which are crucial for increasing the sensitivity of mass spectrometric protein assays.[55.1] The basic mass spectrometry methods, including matrix-assisted laser desorption/ionization time-of-flight MS (MALDI-TOF MS) and liquid chromatography-electrospray ionization MS (LC-ESI-MS), have matured significantly, improving sensitivity, resolution, and scan speed.[58.1] These advancements have synergistically merged with chromatographic technologies and integrated databases/software, facilitating accurate protein identification through the analysis of precursor and product ions generated by collision-induced dissociation (CID) in hybrid MS functions.[58.1] In addition to mass spectrometry, bioinformatics tools have played a pivotal role in proteomics research by enabling the analysis of the vast data generated from techniques such as mass spectrometry and protein sequencing. These tools help parse complex data into coherent insights about molecular and cellular mechanisms, thereby advancing our understanding of biological systems.[46.1] The integration of bioinformatics methods with mass spectrometry has led to the development of comprehensive workflows for protein identification and quantification, which are essential for advancing proteomics research.[48.1] Moreover, the integration of proteomic data with genomic and transcriptomic information has opened new avenues for understanding complex biological systems, particularly in cancer research. This multi-omics approach allows for a comprehensive analysis of molecular interactions and regulatory mechanisms, although it also presents challenges in data integration and interpretation.[52.1] The ongoing evolution of these technologies continues to drive significant milestones in the field of proteomics, enhancing our ability to explore and understand the complexities of life at the molecular level.[50.1]Recent Advancements
Mass-Spectrometry-Based Techniques
Mass spectrometry (MS)-based techniques have significantly advanced the field of proteomics, enabling comprehensive studies of protein expression and post-translational modifications (PTMs).[93.1] Over the past few years, there has been a notable acceleration in the development of various mass spectrometry approaches, particularly within bottom-up proteomics. This includes innovations in high-throughput experiments and the application of machine learning for data analysis, which have collectively enhanced the efficiency and accuracy of protein identification and quantification.[82.1] Recent advancements in mass spectrometry instrumentation have improved mass resolution and expanded the mass range for effective analysis, facilitating the application of "top-down" proteomics without the need for expensive high-field magnets.[83.1] Techniques such as trapped ion mobility spectrometry (TIMS) combined with parallel accumulation-serial fragmentation (PASEF) have emerged, allowing for better fractionation of complex mixtures and increasing the number of tandem mass spectra collected, thereby enhancing protein identification capabilities.[83.1] Moreover, the integration of bioinformatics tools has played a crucial role in the analysis of mass spectrometry data. Sophisticated algorithms and software have been developed to accurately identify and quantify proteins, addressing the complexities and vast amounts of data generated by mass spectrometry.[88.1] These advancements have not only improved the precision of proteomic studies but have also facilitated the exploration of biomarkers and proteomic networks through robust statistical modeling.[84.1] In clinical settings, mass spectrometry-based proteomics is transforming diagnostics by enabling the identification of pathognomonic features that distinguish diseases, such as tumor markers.[91.1] The integration of artificial intelligence with mass spectrometry data is further enhancing the capabilities of clinical proteomics, allowing for early disease detection and the development of personalized treatment strategies.[94.1] Overall, the advancements in mass spectrometry techniques are pivotal in bridging the gap between proteomics technology and clinical applications, significantly impacting disease diagnostics and personalized medicine.[94.1]Integration of Artificial Intelligence
The integration of artificial intelligence (AI) into proteomics has revolutionized data analysis and biomarker discovery, offering unique capabilities beyond traditional methods. AI and machine learning techniques have advanced the modeling of mass spectrometry data, enhancing the precision and efficiency of protein identification and quantification in proteomics studies.[89.1] Collaborative workshops involving proteomics data generators, repository managers, and machine learning experts have been pivotal in exploring AI applications, particularly in multidimensional mass spectrometry-based proteomics analysis.[109.1] AI's ability to integrate data from various omics layers, such as genomics and metabolomics, is crucial for identifying biomarkers that elucidate biological processes. For example, AI models have successfully analyzed gene expression profiles alongside proteomics data to identify biomarkers for early cancer detection, including prostate-specific antigen (PSA), and to predict treatment responses.[110.1] Furthermore, AI-driven analyses have been instrumental in predicting biomarkers associated with Alzheimer's disease, such as amyloid-beta and tau proteins, by integrating imaging and proteomic data.[110.1] In the realm of protein-protein interactions (PPIs), machine learning has been employed since 2001 to predict interactions using the sequence or structure of proteins.[111.1] The extensive protein data generated by high-throughput technologies has enabled the development of sophisticated machine learning models for PPI prediction, enhancing prediction accuracy and expanding research opportunities by utilizing computationally predicted protein structures.[112.1] These advancements underscore AI's transformative role in proteomics, offering distinct advantages in data synthesis and biomarker discovery that complement traditional mass spectrometry and bioinformatics approaches.[112.1]In this section:
Types Of Proteomics
Expression Proteomics
Expression proteomics is a branch of proteomics focused on the study of protein expression levels within biological systems. This field employs various methodologies to detect and quantify proteins, providing insights into their functions and interactions. Techniques commonly used in expression proteomics include two-dimensional gel electrophoresis (2DGE) and mass spectrometry, which are essential for identifying and quantifying proteins from complex biological samples.[129.1] The process of expression proteomics typically involves several critical steps: sample preparation, protein separation, identification, and validation. Sample preparation is particularly crucial, as it entails the extraction and purification of proteins from biological samples, setting the stage for accurate analysis.[129.1] Liquid chromatography (LC) is frequently utilized to separate proteins from complex mixtures, enhancing the efficiency of subsequent analyses.[129.1] In contrast to targeted proteomics, which focuses on quantifying specific proteins, expression proteomics aims to provide a broader overview of the proteome. Targeted proteomics is characterized by its high sensitivity and reproducibility, allowing for the simultaneous measurement of 10-100 target proteins.[130.1] This distinction highlights the complementary nature of both approaches, with expression proteomics offering insights into overall protein expression patterns and targeted proteomics providing detailed quantification of specific proteins of interest. The analysis of expression proteomics data is increasingly supported by advanced bioinformatics tools. These tools facilitate the interpretation of complex datasets generated by high-throughput techniques, enabling researchers to identify patterns of protein expression and co-regulation.[134.1] The development of algorithms for data normalization and differential expression analysis has become essential in ensuring the accuracy and reproducibility of findings in this rapidly evolving field.[134.1] Despite the advancements in expression proteomics, challenges remain in translating these findings into clinical practice. Key barriers include the need for orthogonal biomarkers that are uncorrelated with existing markers, the complexity of the proteome, and the presence of high-abundance proteins that can obscure the detection of low-abundance proteins.[138.1] Furthermore, the integration of expression proteomics into routine diagnostics necessitates comprehensive educational programs and user-friendly interfaces to facilitate its adoption in personalized medicine.[139.1]Structural and Functional Proteomics
Functional proteomics aims to understand the roles, interactions, and activities of proteins within a cellular context. This branch of proteomics provides insights into protein functions, their interactions, and the larger networks they form, which is essential for deciphering molecular mechanisms and aiding drug development.[123.1] In contrast, structural proteomics focuses on understanding protein structures at atomic levels, analyzing protein interactions, and facilitating drug design and discovery.[123.1] The study of proteomics encompasses various techniques that enable researchers to explore the complex proteome, which is the complete set of proteins produced in a biological system. These techniques include mass spectrometry, which identifies and quantifies proteins, and two-dimensional gel electrophoresis (2DGE), which separates proteins based on their size and charge.[125.1] Expression proteomics, a subset of functional proteomics, provides a snapshot of the proteome under specific conditions, while structural proteomics lays the foundation for understanding the architecture of proteins.[127.1] Recent advancements in mass spectrometry and analytical workflows have expanded the scope of proteomics from simple protein profiling to high-throughput quantification of alterations in protein expression and post-translational modifications.[126.1] This evolution allows for a more comprehensive understanding of protein functions and interactions, which is crucial for identifying potential biomarkers and therapeutic targets in various diseases.[126.1]Proteomics In Drug Discovery
Role in Identifying Therapeutic Targets
Proteomics plays a crucial role in identifying therapeutic targets within the drug discovery process. By comparing the proteomic profiles of healthy and diseased states, researchers can identify specific proteins that serve as potential biomarkers for various diseases.[168.1] This capability is essential for understanding the interactions between drugs and their protein targets, as proteomics can reveal how these interactions affect protein function and identify unintended protein targets, which may provide insights into potential side effects or additional therapeutic uses.[168.1] The integration of proteomics with other biochemical approaches has enhanced target identification and validation, allowing for a more comprehensive understanding of disease mechanisms.[166.1] Innovative strategies, such as targeted protein degradation and the use of reactive fragments, have emerged from proteomics approaches, generating unique insights that are critical for early-stage drug discovery.[166.1] Furthermore, proteomics-based technologies are employed to detect diagnostic markers and observe changes in protein expression patterns in response to various stimuli, thereby elucidating functional protein pathways involved in disease.[169.1] Despite its promise, the integration of proteomics into drug discovery is not without challenges. Target identification has historically been a bottleneck in phenotype-based drug discovery, prompting the development of various chemical proteomic methods to address this issue.[172.1] Additionally, the efficiency of drug development has been declining, leading researchers to explore protein-protein interactions (PPIs) as new drug targets, given their abundance and significance in cellular processes.[173.1] Recent advancements in mass spectrometry have significantly improved the accuracy and efficiency of identifying potential drug targets in proteomics. Techniques such as native mass spectrometry (nMS) have been instrumental in maintaining the endogenous properties of proteins during analysis, thereby enhancing the understanding of protein interactions and functions.[177.1] These advancements, combined with bioinformatics tools that facilitate the integration of proteomic data with genomic and other omics data, are paving the way for more effective therapeutic target identification.[175.1] Overall, proteomics continues to evolve as a powerful tool in drug discovery, providing deep insights into protein function and disease mechanisms that are vital for developing novel therapeutics.[171.1]Impact on Biomarker Discovery
Proteomics has significantly impacted biomarker discovery, particularly in the context of drug development and personalized medicine. The integration of proteomic data with genomic and clinical data enhances the identification of biomarkers, although it faces challenges such as the need for accurate data processing and the establishment of common standards for data representation and analysis.[183.1] Multi-omics approaches, which combine various biological data types, have shown promise in revealing novel insights into disease mechanisms and therapeutic responses, thereby identifying new biomarkers and therapeutic targets.[185.1] Proteomic technologies have been extensively utilized for biomarker discovery, leveraging techniques such as mass spectrometry to identify proteins associated with various diseases, including cancer.[190.1] These technologies facilitate the characterization and evaluation of protein profiles, which are crucial for understanding disease states and developing targeted therapies.[191.1] Furthermore, the use of proteomics in drug discovery allows for the identification of potential drug targets and the assessment of drug efficacy through the analysis of protein interactions and modifications.[188.1] Despite the advancements, the process of biomarker discovery remains complex and requires careful evaluation of various factors, including patient demographics and sample types.[189.1] The National Cancer Institute's Early Detection Research Network (EDRN) exemplifies a successful collaborative effort to address these challenges by focusing on the validation of cancer biomarkers through standardized methodologies.[181.1] Overall, the evolving role of proteomics in drug discovery underscores its potential to revolutionize biomarker identification and patient stratification, ultimately contributing to more personalized therapeutic strategies.[191.1]In this section:
Proteomics In Disease Research
Applications in Cancer Research
Recent advancements in mass spectrometry-based clinical proteomics have significantly impacted cancer research, establishing it as a vital component of routine clinical analysis and patient care. These advancements facilitate the large-scale study of proteins, including their expression, functions, and structures, which are crucial for improving patient outcomes in oncology.[221.1] The integration of high-throughput proteomics approaches, such as mass spectrometry, protein pathway arrays, and single-cell proteomics, has enabled researchers to explore complex protein networks and identify biomarkers associated with various cancers.[223.1] Clinical trials increasingly utilize protein and peptide biomarkers for patient stratification, disease diagnosis, and prognosis. A notable trend is the development of non-invasive diagnostic tools aimed at early cancer detection, which is essential for improving treatment efficacy.[224.1] The application of mass spectrometry in these contexts has led to the identification of thousands of potential protein biomarkers across multiple diseases, thereby enhancing the understanding of cancer biology and treatment responses.[231.1] Moreover, innovative methodologies, such as AI-driven image analysis combined with high-resolution mass spectrometry, have emerged, allowing for detailed mapping of protein expression patterns within specific cell types in complex tissues. This approach provides exceptional spatial resolution, which is critical for functional studies in cancer proteomics.[232.1] The versatility of mass spectrometry enables researchers to study various aspects of the proteome, contributing to breakthroughs in cancer research and personalized medicine.[233.1]Insights into Infectious and Noninfectious Diseases
Proteomics has significantly advanced our understanding of both infectious and noninfectious diseases by providing insights into the biochemical and physiological mechanisms underlying these conditions. The comprehensive study of proteins, known as proteomics, plays a crucial role in disease characterization, diagnosis, prognosis, drug development, and therapy.[212.1] By examining the proteome, which encompasses all expressed proteins within a cell, researchers can identify disease-associated pathways and develop targeted therapeutic agents.[214.1] In the context of infectious diseases, proteomics has been instrumental in identifying biomarkers that can aid in the diagnosis and monitoring of disease progression. For instance, the analysis of secreted proteins, or the secretome, has revealed their roles in cell-cell communication and pathophysiological conditions, making them valuable sources for potential biomarkers and therapeutic targets.[220.1] Additionally, proteomics techniques such as mass spectrometry and protein microarrays facilitate the detection of diagnostic markers and the understanding of pathogen-host interactions.[214.1] For noninfectious diseases, proteomics contributes to the elucidation of complex biological processes by integrating with other omics technologies, such as genomics and transcriptomics. This integrative approach allows for a more comprehensive understanding of disease mechanisms, as it enables the simultaneous study of proteins, genes, RNAs, and metabolites.[219.1] For example, proteogenomics, which combines proteomic and genomic data, has provided new insights into diseases like obesity by identifying functional elements and genetic variants associated with disease.[218.1] Moreover, the application of proteomics in drug discovery is noteworthy, as it aids in the identification of drug targets and the characterization of protein interactions within biological systems.[228.1] By leveraging sophisticated techniques, researchers can observe changes in protein expression patterns in response to various stimuli, thereby enhancing our understanding of disease pathogenesis and progression.[227.1]Challenges And Future Directions
Technical Limitations
Mass spectrometry (MS)-based single-cell proteomics faces several technical limitations that hinder its widespread application. Although recent advancements have enabled the analysis of thousands of single cells per day, the sensitivity of these methods still requires improvement, and their throughput remains significantly lower compared to single-cell RNA sequencing (scRNA-seq).[249.1] The authors Mann, Rosenberger, and Thielert highlight that while the foundational technologies for single-cell proteomics are largely established, most applications to date have primarily served as technological proofs of principle, largely due to the limited quantitative depth of coverage achieved thus far.[249.1] Moreover, the complexity of proteomic data presents additional challenges. The vast number of proteins, their diverse post-translational modifications (PTMs), and intricate interactions complicate accurate analysis and interpretation.[253.1] Addressing these issues is crucial for enhancing the quality and reliability of proteomic analyses, particularly in the context of clinical applications where precise biomarker identification is essential.[264.1] The integration of emerging technologies, such as artificial intelligence (AI) and machine learning, offers potential solutions to some of these limitations. These technologies can enhance data analysis and facilitate the development of predictive models for biomarker discovery.[255.1] However, the application of AI in proteomics is still in its infancy, and further research is needed to fully realize its capabilities in addressing current challenges related to sensitivity and throughput in single-cell proteomics.[257.1] In addition to these challenges, the dynamic range of protein expression poses a significant hurdle. Proteins can vary widely in abundance, complicating the detection and quantification processes.[262.1] Furthermore, the integration of non-MS-based single-molecule protein sequencing methods into existing workflows presents its own set of challenges, including the need for improved computational strategies to accurately discriminate between amino acids.[263.1]In this section:
References
[2] Proteomics: Types, Methods, Steps, Applications - Microbe Notes — Proteomics is the study of the proteome, which is the complete set of proteins that are produced in a biological system. Proteomics focuses on the study of proteins, their structures, interactions, and functions. Proteomics can be used to study the expression of proteins. Expression proteomics experiments often use techniques such as 2D gel electrophoresis and mass spectrometry to detect and quantify proteins. Proteomic procedures consist of several steps, including sample preparation, separation of proteins, protein identification, and validation. Sample preparation is a critical step in proteomics experiments, which involves the extraction and purification of proteins from biological samples for further analysis. LC (Liquid chromatography) is one of the most widely used methods in proteomics to separate proteins from complex mixtures.
[4] What Is Proteomics? | The Scientist — Proteomics uses techniques such as mass spectrometry to analyze proteins in different sample types, including cells, tissues, and entire organisms. By generating comprehensive protein datasets, scientists understand the ebb and flow of protein expression in a tissue, how it differs from cell to cell, and how these differences illustrate the inner workings of an organism.1-3 Proteomics is applied in drug discovery, biomarker identification, and understanding diseases at the molecular level. Mass spectrometry (MS)-based proteomics is the most comprehensive approach, allowing researchers to quantify protein levels and discover protein modifications and interactions. M. Turewicz et al., “BioInfra.Prot: A comprehensive proteomics workflow including data standardization, protein inference, expression analysis and data publication,” J Biotechnol, 261:116-25, 2017.
[6] Proteomics: Principles, Techniques and Applications — While genomics and transcriptomics have been the main focus of such studies to date, proteomics data will likely add a further dimension for patient-specific management.Biomarker discoveryIdentification of protein markers e.g., for the diagnosis and prognosis of glioblastoma, and evaluating patients’ response to therapeutic interventions such as stem cell transplantation.Drug discovery and developmentIdentifying potential drug targets, examining the druggability of selected protein targets, and developing drugs aimed at candidate therapeutic protein targets (e.g., for hepatocellular carcinoma).Systems biologySystem-wide investigations of disease pathways and host–pathogen interactions to identify potential biomarkers and therapeutic targets; system-wide investigations of drug action, toxicity, resistance and efficacy.
[7] Role of Proteomics in the Development of Personalized Medicine — Advances in proteomic technologies have made import contribution to the development of personalized medicine by facilitating detection of protein biomarkers, proteomics-based molecular diagnostics, as well as protein biochips and pharmacoproteomics. Advances in proteomic technologies have made a very import contribution of development of personalized medicine by facilitating detection of protein biomarkers, development of proteomics-based molecular diagnostics, and pharmacoproteomics, which will be discussed in the following sections. Global protein profiling can provide a vast amount of information with relevance to many research areas where consistent, accurate, and large-scale protein quantification data are required; examples include but are not limited to biomarker discovery, drug screens, and personalized medicine. Proteomics also plays a role in the development of personalized medicine by enabling the detection of protein biomarkers .
[8] Building the basis for proteomics in personalized medicine for targeted ... — Proteomics, provides functional information concerning the activity of key regulating protein target(s) in disease, that the precision medicine has been developed for. The drug agency, MLWH in Japan played an important role in these developments, requesting additional detailed data that linked the treatment of lung cancer patients to optimal efficacy and safety. Understanding the mechanisms of drug action is key, in order to optimally design and develop drug molecules that provide optimal treatments for patients. Fehniger and Marko-Varga were the first to introduce drug localization data in lung cancer-, and COPD- clinical studies, after drug administration . Finally, personalized medicine represents a paradigm shift with drug development research and therapy that changes patient treatments on a daily basis.
[9] An interactive atlas of genomic, proteomic, and metabolomic ... - Nature — We used machine learning to build predictive models for different combinations of genetic variants, proteins, and metabolites, and these models were utilized to search for potential biomarkers for the incidence and prevalence of nine complex diseases (Fig. 1). (A) Genomic, proteomic, and metabolomic data from patients with (B) nine incident or prevalent complex diseases and age/sex matched controls were (C1) analysed using cross-validation and holdout test datasets, and (C2) A polygenic risk score was computed for genomic data, while (D) feature selection was performed for proteomics and metabolomics. Our comparison of genomic, proteomic, and metabolomic data provides a systematic solution for the prioritisation of the type and number of potential biomarkers for the incidence and prevalence of nine common complex diseases.
[10] Multi-omics integration in biomedical research - A metabolomics-centric ... — This has led to the generation of vast amounts of biological data that can be integrated in so-called multi-omics studies to examine the complex molecular underpinnings of health and disease. Therefore, combining omics data from multiple biological domains (e.g., levels of transcripts, proteins, or metabolites) in multi-omics studies is a promising approach towards a more detailed molecular understanding of health and disease, as well as the chain of cause and effect, which is an essential requirement for guiding novel therapies . In this review, we will provide an overview over a typical multi-omics workflow, focusing on integration methods that have the potential to combine metabolomics data with more than two omics and highlighting their application in recent multi-omics studies. Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data
[11] Advancements in mass spectrometry-based proteomics: a new era in ... — Advancements in mass spectrometry-based proteomics: a new era in pathology research and diagnostics | Die Pathologie Mass spectrometry (MS)-based proteomics is rapidly transforming pathology research and diagnostics by enabling comprehensive studies of protein expression and post-translational modifications (PTMs). This article discusses recent advancements in MS-based proteomics, focusing on emerging technologies in sample preparation, MS instrumentation, and data analysis. The article reviews innovations in automated sample preparation, chromatography systems, advanced MS technologies, and proteomic data analysis in the context of pathology. Fröhlich K, Fahrner M, Brombacher E et al (2024) Data-Independent Acquisition: A Milestone and Prospect in Clinical Mass Spectrometry—Based Proteomics. Fröhlich K, Fahrner M, Brombacher E et al (2024) Data-Independent Acquisition: A Milestone and Prospect in Clinical Mass Spectrometry—Based Proteomics.
[13] Recent Advances in Mass Spectrometry-Based Protein Interactome Studies — In BriefThis review highlights recent advancements in mass spectrometry-based techniques for mapping protein interactomes, including affinity purification, proximity labeling, cross-linking, and co-fractionation approaches. It discusses the integration of these methods with cutting-edge computational tools, emphasizing their synergistic potential in elucidating complex cellular networks. The
[14] Mass-spectrometry-based proteomics: from single cells to clinical ... — Mass-spectrometry-based proteomics: from single cells to clinical applications | Nature Mass-spectrometry-based proteomics: from single cells to clinical applications This study introduces DVP, which combines AI-driven image analysis with high-resolution mass spectrometry to map protein expression patterns in specific cell types within complex tissues, enabling exceptional spatial resolution for functional studies in proteomics. We acknowledge the following for financial support: the National Natural Science Foundation of China (Major Research Plan, grant 92259201), the National Key R&D Program of China (grant 2021YFA1301600) and the Westlake Education Foundation (to T.G.); the Max Planck Society for the Advancement of Science (to M.M.); and the National Institutes of Health National Institute on Aging (R01 AG071858), the Rainwater Foundation and the Ellison Foundation (to J.A.S.).
[15] Mapping protein-protein interactions by mass spectrometry — Protein-protein interactions (PPIs) are essential for numerous biological activities, including signal transduction, transcription control, and metabolism. They play a pivotal role in the organization and function of the proteome, and their perturbation is associated with various diseases, such as cancer, neurodegeneration, and infectious diseases.
[40] History of Proteomics — Proteomics: The Systematic, High-Throughput Approach to Protein Expression Analysis of a Cell or an Organism. Proteomics is the scientific discipline which studies proteins and searches for proteins that are associated with a disease by means of their altered levels of expression and/or post-translational modification between control and disease states. Detailed analysis of the proteome permits the discovery of new protein markers for diagnostic purposes and of novel molecular targets for drug discovery. Proteomic Services By allowing these third party services, you accept their cookies and the use of tracking technologies necessary for their proper functioning. The audience measurement services used to generate useful statistics attendance to improve the site. Support services allow you to get in touch with the site team and help to improve it.
[42] Proteomics - Wikipedia — Although early large-scale shotgun proteomics analyses showed considerable variability between laboratories, presumably due in part to technical and experimental differences between laboratories, reproducibility has been improved in more recent mass spectrometry analysis, particularly on the protein level. Notably, targeted proteomics shows increased reproducibility and repeatability compared with shotgun methods, although at the expense of data density and effectiveness. Mass spectrometry-based methods, affinity proteomics, and micro arrays are the most common technologies for large-scale study of proteins. As an example, The Cancer Proteome Atlas provides quantitative protein expression data for ~200 proteins in over 4,000 tumor samples with matched transcriptomic and genomic data from The Cancer Genome Atlas. Similar datasets in other cell types, tissue types, and species, particularly using deep shotgun mass spectrometry, will be an immensely important resource for research in fields like cancer biology, developmental and stem cell biology, medicine, and evolutionary biology. doi:10.3390/proteomes8030014. doi:10.3390/proteomes3040440.
[43] After the Genome—A Brief History of Proteomics — Defining Moment. Although initial studies that could be considered proteomics were published nearly 50 years ago, a team of researchers including Marc Wilkins, DSc, PhD—currently a professor of systems biology at The University of New South Wales (UNSW) in Sydney, Australia—didn't coin the term proteome until 1994. Then a doctoral student attending a 2D electrophoresis conference in
[46] From data to discovery: The essential role of computational tools in ... — Proteomics research, a cornerstone of 'omics studies, provides a panoramic view into the molecular and cellular mechanisms underpinning life. ... bioinformatics and computational tools blend complex data into a coherent understanding of life's molecular foundations. This special issue stands as a testament to the power of computational mass
[48] Bioinformatics Methods for Mass Spectrometry-Based Proteomics Data ... — Bioinformatics Methods for Mass Spectrometry-Based Proteomics Data Analysis - PubMed Bioinformatics Methods for Mass Spectrometry-Based Proteomics Data Analysis Bioinformatics Methods for Mass Spectrometry-Based Proteomics Data Analysis We first introduce bioinformatics software and tools designed for mass spectrometry-based protein identification and quantification, and then we review the different statistical and machine learning methods that have been developed to perform comprehensive analysis in proteomics studies. General workflow of bioinformatics analysis in mass spectrometry-based proteomics. General workflow of bioinformatics analysis in mass spectrometry-based proteomics. (c) Heatmap for protein abundance with clustering; (d) Protein set enrichment analysis, Y-axis in the above plot shows the ranked list metric, and in the bottom plot shows the running enrichment score. Illustration of enrichment analysis with proteomics data.
[50] Cancer proteomics, current status, challenges, and future outlook — The study of proteomics and genomics together has the potential to have a significant impact on future biomedical research and the development of next-generation diagnostic and therapeutic techniques.
[52] Multi-OMICS approaches in cancer biology: New era in cancer therapy — The landscape of cancer research has undergone a paradigm shift towards multi-omics techniques, thanks to advancements in HTT in transcriptomics and genomics, increased collaboration in large-scale research, and improvements in computational algorithms.
[55] Advantageous Uses of Mass Spectrometry for the Quantification of ... — Better sample simplification procedures are often the key to increased sensitivity of mass spectrometric protein assays. Perhaps the major limitation to mass-spectrometry-based protein quantification is throughput. Immunological assays can be performed in 96- or 384-well format. Plate readers can measure readouts of entire plates in batch mode.
[56] Protein Identification by Mass Spectrometry - Molecular & Cellular ... — During the past two decades, mass spectrometry has become established as the primary method for protein identification from complex mixtures of biological origin. This is largely attributable to the fortunate coincidence of instrumental advances that allow routine analysis of minute amounts (typically femtomoles) of involatile, polar compounds such as peptides in complex mixtures, with the
[58] Recent advances in mass spectrometry-based approaches for proteomics ... — Recent advances in mass spectrometry-based approaches for proteomics and biologics: Great contribution for developing therapeutic antibodies - ScienceDirect The basic MS methods used for proteomics are matrix-assisted laser desorption/ionization time-of-flight MS (MALDI-TOF MS) (Fukuyama, Nakaya, Yamazaki, & Tanaka, 2008) and liquid chromatography-electrospray ionization MS (LC-ESI-MS) (Mora et al., 2000), and in the past two decades, they have drastically matured improving the basic potential for sensitivity, resolution, and scan speed that synergistically merge with the chromatographic technology and integrated databases/software (Ghaste et al., 2016, Hardman and Makarov, 2003). Currently, in the proteomic field with MS, accurate protein identification is generally performed using a dataset of precursor and product ions generated by collision-induced dissociation (CID) in hybrid MS function.
[76] After the Genome—A Brief History of Proteomics — With researchers touting recent success in sequencing the human genome’s remaining gaps, an emerging frontier is proteomics: identifying and studying an entire set of expressed proteins in the human body and other organisms. Another article coauthored by Wilkins in Biotechnology and Genetic Engineering Reviews went further to define the term: “As an extrapolation of the concept of the ‘genome project’, a ‘proteome project’ is research which seeks to identify and characterise the proteins present in a cell or tissue and define their patterns of expression.” “The good news is that we can kind of predict the number of proteins that should be in the human proteome from the genome,” said Wilkins, a council member of HUPO who isn’t involved formally with the HPP.
[79] Transformative Impact of Proteomics on Cardiovascular Health and ... — The year 2014 marked the 20th anniversary of the coining of the term proteomics. The purpose of this scientific statement is to summarize advances over this period that have catalyzed our capacity to address the experimental, translational, and clinical implications of proteomics as applied to cardiovascular health and disease and to evaluate the current status of the field.
[82] Proteomics: An In‐Depth Review on Recent Technical Advances and Their ... — Moreover, we summarize the cutting-edge technologies and potential breakthroughs in the proteomics pipeline and provide the principal challenges in proteomics. Based on these, we aspire to broaden the applicability of proteomics and inspire researchers to enhance our understanding of complex biological systems by utilizing such techniques.
[83] Recent technical advances in proteomics - PMC - PubMed Central (PMC) — Improvements in mass resolution in these instruments resulted in an increase in the mass range for effective analysis, precipitating greater interest in the “top down” proteomics which now could be performed without expensive high-field magnets previously required for ion cyclotron resonance MS of intact proteins 21– 23. Combining these methods (TIMS/PASEF) provides another means to fractionate complex mixtures of ions to increase the number of tandem mass spectra of peptides collected and thus the number of protein identifications. High-resolution ion separations have enabled improved mass spectrometer performance for analysis of intact proteins with less sophisticated instruments which has increased interest in the application of top-down proteomics to biological problems.
[84] High-throughput proteomics: a methodological mini-review — Here, we summarize scientific research and clinical practice of existing and emerging high-throughput proteomics approaches, including mass spectrometry, protein pathway array, next-generation tissue microarrays, single-cell proteomics, single-molecule proteomics, Luminex, Simoa and Olink Proteomics. Then, the immunofluorescence signals of antibody-antigen reactions are converted to numeric data as the value of protein expression by Quantity One (https://www.bio-rad.com/en-us/category/image-lab-software-suite?ID=5291f579-0715-48f4-b3de-766b92222582) from Bio-Rad. The biomarkers and proteomic networks can be explored and trained after data normalization and appropriate statistic modeling. SAM, a Microsoft Excel add-in package, is a widely used high-throughput permutation-based approach to identify differentially expressed proteins between sets of samples in abundance proteomics data using modified t-statistics (q-value) which measures the strength of the relationship between protein abundance and disease outcome86.
[88] Bioinformatics tools to identify and quantify proteins using mass ... — We also discuss the bioinformatics algorithms and software to quantify proteins and detect the differential proteins using isotope-coded affinity tags and label-free mass spectrometry data. Keywords: Bioinformatics; Mass spectrometry; Protein identification; Protein quantification; Proteomics; Software.
[89] Overview of Recent Advancements in Proteomics Bioinformatics Tools — The field of proteomics bioinformatics is dynamic, with ongoing advancements, new tools, and evolving methodologies. Researchers are urged to stay updated with the latest developments in proteomics bioinformatics to leverage emerging technologies, methodologies, and resources.
[91] Proteomics In Clinical Laboratory Diagnosis - ScienceDirect — The key to making an accurate diagnosis is in identifying the pathognomonic features of a specimen that unmistakably distinguish it. Practical clinical applications such as tumor markers and disease-related applications are also discussed in this chapter. ... Cancer proteomics: Serum diagnostics for tumor marker discovery. Ann NY Acad Sci, 1022
[93] Advancements in mass spectrometry-based proteomics: a new era in ... — Background: Mass spectrometry (MS)-based proteomics is rapidly transforming pathology research and diagnostics by enabling comprehensive studies of protein expression and post-translational modifications (PTMs). Objective: This article discusses recent advancements in MS-based proteomics, focusing on emerging technologies in sample preparation, MS instrumentation, and data analysis.
[94] Bridging the Gap From Proteomics Technology to Clinical Application ... — Bridging the Gap From Proteomics Technology to Clinical Application: Highlights From the 68th Benzon Foundation Symposium - ScienceDirect Bridging the Gap From Proteomics Technology to Clinical Application: Highlights From the 68th Benzon Foundation Symposium Mass spectrometry–based proteomics is ready to transform clinical diagnostics. AI transforms proteomic data acquisition, analysis, and clinical decision support. The 68th Benzon Foundation Symposium brought together leading experts to explore the integration of mass spectrometry–based proteomics and artificial intelligence to revolutionize personalized medicine. This report highlights key discussions on recent technological advances in mass spectrometry–based proteomics, including improvements in sensitivity, throughput, and data analysis. clinical proteomics For all open access content, the Creative Commons licensing terms apply.
[109] Toward an Integrated Machine Learning Model of a Proteomics Experiment — In recent years machine learning has made extensive progress in modeling many aspects of mass spectrometry data. We brought together proteomics data generators, repository managers, and machine learning experts in a workshop with the goals to evaluate and explore machine learning applications for realistic modeling of data from multidimensional mass spectrometry-based proteomics analysis of
[110] AI in Proteomics Data Analysis: Revolutionizing Protein Research — AI in Proteomics Data Analysis: Revolutionizing Protein Research | Research Communities by Springer Nature AI combines data from multiple omics layers (e.g., genomics, proteomics, metabolomics) to identify biomarkers that span different biological processes. AI models analyze gene expression profiles and proteomics data to identify biomarkers for early cancer detection (e.g., PSA for prostate cancer) and treatment response. Biomarkers for Alzheimer's disease, such as amyloid-beta or tau proteins, are predicted using AI-driven analysis of imaging and proteomic data. Federated Learning: Sharing AI models without transferring sensitive data enables biomarker prediction across multiple institutions. Use Case: Building custom neural networks for biomarker discovery in high-dimensional data like proteomics and genomics. Use Case: Explaining feature contributions to AI model predictions, making biomarker discovery interpretable.
[111] Machine-learning techniques for the prediction of protein-protein ... — The use of machine-learning techniques in the prediction of PPIs began in 2001 through the independent efforts of a few research groups (Bock and Gough 2001; Sprinzak and Margalit 2001; Zhou and Shan 2001).The prediction of binary PPIs generally involves the sequence or structure of both the interacting proteins as the input and the probability of these two proteins to interact with each other
[112] Machine learning on protein-protein interaction prediction: models ... — Machine learning on protein-protein interaction prediction: models, challenges and trends - PubMed Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Machine learning on protein-protein interaction prediction: models, challenges and trends Machine learning on protein-protein interaction prediction: models, challenges and trends In recent years, benefiting from the enormous amount of protein data produced by advanced high-throughput technologies, machine learning models have been well developed in the field of PPI prediction. Finally, we highlight potential directions in PPI prediction, such as the use of computationally predicted protein structures to extend the data source for machine learning models. Machine Learning Methods for Virus-Host Protein-Protein Interaction Prediction. doi: 10.1007/978-1-0716-3327-4_31. doi: 10.1007/978-1-0716-1641-3_16. Prediction of Protein-Protein Interaction Sites with Machine-Learning-Based Data-Cleaning and Post-Filtering Procedures. doi: 10.2174/1573406413666170522150940.
[123] Comprehensive Guide to Proteomics Types: Delving into Expression ... — A. Definition and Scope Functional proteomics aims to understand the roles, interactions, and activities of proteins in the cellular context. In conclusion, functional proteomics, through the use of these and other techniques, provides an in-depth understanding of protein functions, their interactions, and the larger networks they form. Structural Proteomics: Used in understanding protein structures at atomic levels, analyzing protein interactions, and facilitating drug design and discovery. Expression proteomics gives a snapshot of the proteome at a given time or condition, functional proteomics deciphers the roles and interactions of these proteins, and structural proteomics provides a detailed view of the protein’s architecture, laying the foundation for understanding molecular mechanisms and aiding drug development.
[125] Understanding proteomics: Techniques and applications - Abcam — Proteomics is the large-scale study of proteins, particularly their functions and interactions within a biological system. These techniques enable researchers to explore the complex proteome and gain insights into protein functions, structures, and interactions. Single-cell proteomics is a method that studies protein expression in individual cells, revealing insights into cellular diversity, development, and disease progression. Proteomics investigates protein expression, activity, and interactions. Proteomics techniques include mass spectrometry, which identifies and quantifies proteins; two-dimensional gel electrophoresis (2DGE), which separates proteins based on their size and charge; shotgun proteomics, a bottom-up approach for identifying proteins in complex mixtures using high-performance liquid chromatography and mass spectrometry, which analyzes complex mixtures; affinity-based methods, such as co-immunoprecipitation, to study protein interactions; and the use of protein microarrays for high-throughput analysis of protein interactions and activities.
[126] Proteomics - an overview | ScienceDirect Topics — Continuous improvements in ultrasensitive mass spectrometry techniques, along with the rapidly emerging analytical workflows and data analysis strategies, expand proteomics from mere protein profiling to high-throughput quantification of alterations in protein expression (Filiou et al., 2012), post-translational modifications (Jensen, 2006), and protein–protein interactions (Ho et al., 2002; Ping, 2003; Kocher and Superti-Furga, 2007). As reviewed in Sections 3 and 4, gel-based and gel-free techniques of protein analysis using mass spectrometry and isotope labeling-based or label-free techniques for relative quantification for protein expression between glaucomatous and control samples have been increasingly used to study molecular mechanisms and identify potential biomarker candidates of glaucoma.
[127] Proteomics: Introduction, Methods, Types and Application — The entire collection of proteins that an organism produces is called its proteome. Thus proteomics is the study of the proteome or the array of proteins an organism can produce. Proteomics provides information about genome function that mRNA studies cannot because a direct correlation between mRNA and the pool of cellular proteins does not always exist. Two-dimensional gel electrophoresis can resolve thousands of proteins; each protein is visualized as a spot of varying intensity, depending on its cellular abundance. Sometimes proteins or collections of fragments are run through two mass spectrometers in sequence, a process known as tandem MS. The sequence of a whole protein often can be determined by analysis of such fragment sequence data. https://www.deepdyve.com/lp/wiley/from-protein-to-the-beginnings-of-clinical-proteomics-bCZMdrNTRk
[129] Proteomics: Types, Methods, Steps, Applications - Microbe Notes — Proteomics is the study of the proteome, which is the complete set of proteins that are produced in a biological system. Proteomics focuses on the study of proteins, their structures, interactions, and functions. Proteomics can be used to study the expression of proteins. Expression proteomics experiments often use techniques such as 2D gel electrophoresis and mass spectrometry to detect and quantify proteins. Proteomic procedures consist of several steps, including sample preparation, separation of proteins, protein identification, and validation. Sample preparation is a critical step in proteomics experiments, which involves the extraction and purification of proteins from biological samples for further analysis. LC (Liquid chromatography) is one of the most widely used methods in proteomics to separate proteins from complex mixtures.
[130] Targeted Proteomics vs. Untargeted Proteomics - This vs. That — In conclusion, targeted proteomics and untargeted proteomics are two distinct approaches in proteomics research, each with its own strengths and limitations. Targeted proteomics offers high sensitivity, reproducibility, and quantification accuracy, making it suitable for studying specific proteins or peptides of interest.
[134] Proteomics Data Analysis: Advanced Insights and Approaches — Proteomics data analysis is essential for understanding biological systems by examining protein expression, interactions, and modifications. As datasets grow in complexity, advanced methods are required to extract meaningful insights while ensuring accuracy and reproducibility.
[138] Bridging the Gap From Proteomics Technology to Clinical Application ... — Particular emphasis was placed on plasma proteomics and its potential for biomarker discovery across various diseases. The symposium addressed critical challenges in translating proteomic discoveries to clinical practice, including standardization, regulatory considerations, and the need for robust "business cases" to motivate adoption.
[139] Bridging the Gap From Proteomics Technology to Clinical Application ... — The discussion underscored the importance of developing comprehensive educational programs and user-friendly interfaces to facilitate the integration of proteomics into routine clinical practice. This multifaceted approach to education and training was seen as critical for realizing the full potential of proteomics in personalized medicine.
[166] The emerging role of mass spectrometry-based proteomics in drug discovery — The emerging role of mass spectrometry-based proteomics in drug discovery | Nature Reviews Drug Discovery Skip to main content Thank you for visiting nature.com. Novel biochemical approaches, in combination with recent developments in mass spectrometry-based proteomics instrumentation and data analysis pipelines, have now enabled the dissection of disease phenotypes and their modulation by bioactive molecules at unprecedented resolution and dimensionality. In this Review, we describe proteomics and chemoproteomics approaches for target identification and validation, as well as for identification of safety hazards. We discuss innovative strategies in early-stage drug discovery in which proteomics approaches generate unique insights, such as targeted protein degradation and the use of reactive fragments, and provide guidance for experimental strategies crucial for success.
[168] Proteomics in Drug Discovery: A Revolution in Pharma — Proteomics Protein Separation Techniques in Proteomics By comparing the proteomic profiles of healthy and diseased states, researchers can identify proteins that serve as potential biomarkers. Proteomics can reveal the specific proteins a drug binds to and how this interaction affects the protein’s function. Proteomics can help identify unintended protein targets of a drug, giving insights into potential side effects or additional therapeutic uses. 2. CRISPR/Cas Systems: Though primarily a genomic tool, CRISPR is starting to find applications in proteomics, allowing researchers to target specific proteins or modifications for analysis. 1. Off-target Effects: Proteomics can identify unintended protein interactions of existing drugs, which could hint at new therapeutic uses for already approved drugs. Latest Breakthroughs in Targeted Protein Degradation ---------------------------------------------------- proteomics
[169] Proteomics and Its Current Application in Biomedical Area: Concise ... — Proteomics-based technologies find application in diverse biomedical contexts, including the detection of diagnostic markers, understanding pathogenesis, observing changes in protein expression patterns in response to internal or external signals, and interpreting functional protein pathways in various diseases . They also play a crucial role in drug discovery and the identification of
[171] PDF — Proteomics in drug discovery: Challenges and opportunities. 2024; 8(4):221 Proteomics in drug discovery: Challenges and opportunities. Kamil Verma* School of Biological and Environmental Sciences, Shoolini University of Biotechnology and Management Sciences, Himachal Pradesh, India Proteomics, the large-scale study of proteins, has emerged as a powerful tool in drug discovery. However, the integration of proteomics into drug discovery is not without challenges. Proteomics holds immense promise for transforming drug discovery by providing deep insights into protein function, disease mechanisms, and therapeutic targets. While challenges remain, ongoing advancements in technology, data analysis, and collaborative efforts are paving the way for proteomics to become an integral part of the drug discovery pipeline. Proteomics in drug discovery: Challenges and opportunities. Quantitative proteomics in drug discovery and development.
[172] Recent advances in identifying protein targets in drug discovery — Target identification has been a major bottleneck process in phenotype-based drug discovery, and various chemical proteomic methods have been developed to tackle the issue. Ha et al. focus on the technical advancements and provide recent examples in target identification from covalent capturing to label-free strategies.
[173] Current Challenges and Opportunities in Designing Protein-Protein ... — It has been noticed that the efficiency of drug development has been decreasing in the past few decades. To overcome the situation, protein-protein interactions (PPIs) have been identified as new drug targets as early as 2000. PPIs are more abundant in human cells than single proteins and play numerous important roles in cellular processes including diseases. However, PPIs have very different
[175] Bioinformatics Tools for Drug Discovery - Omics tutorials — In the context of drug discovery, bioinformatics serves as a cornerstone, facilitating the integration of genomics, proteomics, and other omics data to unravel the intricacies of diseases and identify potential drug targets. Bioinformatics tools analyze biological data to identify and validate potential drug targets, including genes, proteins, and pathways associated with specific diseases. In drug discovery, bioinformatics tools play a pivotal role in various aspects, including molecular docking, sequence analysis, and drug target identification. Bioinformatics Contribution: Analysis of HIV genomic data and identification of potential drug targets. From genomic and proteomic analyses to virtual screening and in silico drug design, bioinformatics tools have been instrumental in unraveling the complexities of diseases and guiding the development of targeted and effective therapeutics.
[177] Traversing the drug discovery landscape using native mass spectrometry ... — Native mass spectrometry (nMS) is one approach assisting in overcoming challenges across the drug discovery pipeline. This methodology has been contributing to drug discovery since the early 2000s; specific developments are highlighted in Figure 1.Briefly, in native MS proteins are introduced from solution into the gas phase whilst maintaining many of their endogenous properties .
[181] Cancer biomarker discovery and translation: proteomics and beyond — In summary, genomic analysis has led to the discovery of many genetic variants that are currently used as cancer biomarkers in lab-developed tests, but in the absence of corresponding proteomic and cell signaling data, these mutations have limited diagnostic, prognostic and therapeutic value. Additionally, translational studies aimed at cancer biomarker discovery with the goal of identifying genomic, proteomic, or other carcinogenic profiles to be used in a clinical setting, face numerous challenges including method validation, standardization of sample collection and testing procedures, as well as storage and accessibility to patient data. The NCI EDRN initiative is a prime example of a successful multi-organization translational research program aimed at the discovery of cancer biomarkers for early detection and risk assessment, where collaboration among academic institutions, industry, and government has been able to address challenges including analytical and clinical validation that require large specimen cohorts and standardized sample preparation .
[183] Challenges and Opportunities in Proteomics Data Analysis — Accurate, consistent, and transparent data processing and analysis are integral and critical parts of proteomics workflows in general and for biomarker discovery in particular. Definition of common standards for data representation and analysis and the creation of data repositories are essential to compare, exchange, and share data within the community. Current issues in data processing
[185] Multi-Omics Integration for the Design of Novel Therapies and the ... — By combining different types of omics data, multi-omics can reveal novel insights into the molecular basis of diseases and drug responses, identify new biomarkers and therapeutic targets, and predict and optimize individualized treatments. Multi-omics for drug discovery is a very exciting and promising field that aims to integrate and analyze data from different levels of biological molecules, such as DNA, RNA, proteins, and metabolites, to find new drugs and biomarkers for various diseases. By analyzing data from various omics levels, such as the genome, transcriptome, proteome, metabolome, and microbiome, multi-omics integration can explore complex biological systems and find new biomarkers and therapeutic targets for different diseases, especially cancer. Graw, S.; Chappell, K.; Washam, C.L.; Gies, A.; Bird, J.; Robeson, M.S., 2nd; Byrum, S.D. Multi-omics data integration considerations and study design for biological systems and disease.
[188] The emerging role of mass spectrometry-based proteomics in drug discovery — The emerging role of mass spectrometry-based proteomics in drug discovery | Nature Reviews Drug Discovery Skip to main content Thank you for visiting nature.com. Novel biochemical approaches, in combination with recent developments in mass spectrometry-based proteomics instrumentation and data analysis pipelines, have now enabled the dissection of disease phenotypes and their modulation by bioactive molecules at unprecedented resolution and dimensionality. In this Review, we describe proteomics and chemoproteomics approaches for target identification and validation, as well as for identification of safety hazards. We discuss innovative strategies in early-stage drug discovery in which proteomics approaches generate unique insights, such as targeted protein degradation and the use of reactive fragments, and provide guidance for experimental strategies crucial for success.
[189] Proteomics techniques in protein biomarker discovery — Biomarker investigation for any disease, particularly cancer, must be evaluated carefully before starting any treatment. A biomarker discovery study should consist of the following steps: determination of the disease type, the number of patients and controls, choice of patients (age, sex, etc.), type of samples, etc. . As previously mentioned
[190] Proteomics approach and techniques in identification of reliable ... — The purpose of this review is to summarize the use of proteomics approach and techniques to identify proteins as biomarkers for different diseases. Techniques and methods of proteomics approach are used for the identification of proteins' activities and presence as biomarkers for different types of diseases from different types of samples. There are several proteomics techniques to identify proteins involving; tissue array, and mass spectrometry (MS) and its different forms (Liu et al., 2014, Roy and Shukla, 2008, Wang et al., 2015, Mellon, 2003, Cao and Limbach, 2017). Because of the accuracy and sensitivity of mass measurements, MS became the most important basic technique that is used to identify proteins in proteomics approach especially in the application of tumor marker identification (Wang et al., 2015, Mellon, 2003, Cao and Limbach, 2017).
[191] Role of Proteomics in the Development of Personalized Medicine — Advances in proteomic technologies have made import contribution to the development of personalized medicine by facilitating detection of protein biomarkers, proteomics-based molecular diagnostics, as well as protein biochips and pharmacoproteomics. Advances in proteomic technologies have made a very import contribution of development of personalized medicine by facilitating detection of protein biomarkers, development of proteomics-based molecular diagnostics, and pharmacoproteomics, which will be discussed in the following sections. Global protein profiling can provide a vast amount of information with relevance to many research areas where consistent, accurate, and large-scale protein quantification data are required; examples include but are not limited to biomarker discovery, drug screens, and personalized medicine. Proteomics also plays a role in the development of personalized medicine by enabling the detection of protein biomarkers .
[212] Diagnostic and Therapeutic Application of Proteomics in Infectious Disease — Proteomics, or the comprehensive study of proteins, has emerged as an important technology for disease characterization, diagnosis, prognosis, drug development, and therapy. ... A wide-ranging understanding of disease-associated pathways often plays an important role in designing an agent to inhibit or increase a certain chemical pathway or
[214] Understanding proteomics: Techniques and applications - Abcam — Proteomics is the large-scale study of proteins, particularly their functions and interactions within a biological system. These techniques enable researchers to explore the complex proteome and gain insights into protein functions, structures, and interactions. Single-cell proteomics is a method that studies protein expression in individual cells, revealing insights into cellular diversity, development, and disease progression. Proteomics investigates protein expression, activity, and interactions. Proteomics techniques include mass spectrometry, which identifies and quantifies proteins; two-dimensional gel electrophoresis (2DGE), which separates proteins based on their size and charge; shotgun proteomics, a bottom-up approach for identifying proteins in complex mixtures using high-performance liquid chromatography and mass spectrometry, which analyzes complex mixtures; affinity-based methods, such as co-immunoprecipitation, to study protein interactions; and the use of protein microarrays for high-throughput analysis of protein interactions and activities.
[218] Insights from multi-omics integration in complex disease primary ... — Genome-wide association studies (GWAS) have provided insights into the genetic basis of complex diseases. In the next step, integrative multi-omics approaches can characterize molecular profiles in relevant primary tissues to reveal the mechanisms that underlie disease development. Here, we highlight recent progress in four examples of complex diseases generated by integrative studies: type 2
[219] Multilevel omics for the discovery of biomarkers and ... - Nature — The integration of these multi-omics data means that thousands of proteins (proteomics), genes (genomics), RNAs (transcriptomics) and metabolites (metabolomics) can be studied simultaneously
[220] Coupling enrichment methods with proteomics for understanding and ... — For example, secreted proteins, also referred to as the secretome, can play important roles in cell-cell communication, growth, and, as they can reflect the various stages of pathophysiological conditions , represent a useful source of biomarkers and potential targets to treat disease. Various proteomics approaches have been used to discover
[221] Recent advances in mass spectrometry based clinical proteomics ... — Recent advances in mass spectrometry based clinical proteomics: applications to cancer research | Clinical Proteomics | Full Text Recent advances in mass spectrometry based clinical proteomics: applications to cancer research Recent advances in mass spectrometry based clinical proteomics: applications to cancer research Overall, these advancements not only solidify MS-based clinical proteomics’ integral position in cancer research, but also accelerate the shift towards becoming a regular component of routine analysis and clinical practice. This makes clinical proteomics a growing field in molecular clinical research: the large-scale study of proteins, including their expression, functions and structure, and applying the findings to improve patient care. In this review, we highlight relevant literature related to MS-based clinical proteomics with a specific focus on cancer research. Overview of clinical cancer proteomics strategies.
[223] The Circulating Proteome Technological Developments, Current Challenges ... — There is an ever-growing interest in using these novel methods for studying the circulating proteome, as blood offers an accessible window into human health. As representatives of HUPO’s Human Plasma Proteome Project (HPPP), we present our 2024 survey of the current progress in our community, including the latest build of the Human Plasma Proteome PeptideAtlas that now comprises 4608 proteins detected in 113 data sets. We then discuss the updates of established proteomics methods, emerging technologies, and investigations of proteoforms, protein networks, extracellualr vesicles, circulating antibodies and microsamples. Finally, we provide a prospective view of using the current and emerging proteomics tools in studies of circulating proteins. For all open access content, the Creative Commons licensing terms apply.
[224] Implementation of Proteomics in Clinical Trials - PubMed — Forty-two clinical trials involving the direct use of protein or peptide biomarkers in patient stratification and/or disease diagnosis and prognosis are highlighted. Most of the clinical trials that include proteomics/protein assays are aiming toward implementation of non-invasive diagnostic tools for early detection, while many of the clinical
[227] Proteomics and Its Current Application in Biomedical Area: Concise ... — Various sophisticated techniques are employed in proteomics, including polyacrylamide gel electrophoresis, mass spectrometry analysis, NMR spectroscopy, protein microarray, X-ray crystallography, and Edman sequencing. Proteomics involves the study of all proteins expressed in a cell or organism, with a focus on their composition, structure, function, interaction, expression profiling, and modifications . Proteomics-based technologies find application in diverse biomedical contexts, including the detection of diagnostic markers, understanding pathogenesis, observing changes in protein expression patterns in response to internal or external signals, and interpreting functional protein pathways in various diseases . Proteomics involves the examination of the proteome, which refers to the complete collection of expressed proteins within a cell. M. Proteomics in drug discovery.
[228] Proteomics Applications in Health: Biomarker and Drug Discovery and ... — Proteomics Applications in Health: Biomarker and Drug Discovery and Food Industry - PMC Proteomic experiments can be used for different aspects of clinical and health sciences such as food technology, biomarker discovery and drug target identification. Proteomics is also used in drug target identification using different approaches such as chemical proteomics and protein interaction networks. Since proteins and interaction between them are fundamental in biological systems, proteomics can also be a valuable approach for drug target discovery. Proteomics technology is powerful tool for biomarker discovery through characterization and evaluation of global profiling of proteins under given state J. Proteomics . J. Proteomics . J. Proteome. J. Proteomics . J. Proteome Res. 2007;6:1245–57. J. Proteomics . J. Proteome Res. 2012;11:4201–10.
[231] Mass spectrometry-based proteomics as an emerging tool in clinical ... — This review article highlights the new paradigms MS-based clinical proteomics has created in microbiology laboratories, cancer research and diagnosis of metabolic disorders. During the last decades, MS-based proteomics has led to the discovery and identification of thousands of potential protein biomarkers for a number of diseases . Kontostathi et al., (2019) has presented a summary of studies based on MRM targeted proteomic assays to discover and validate diseases specific biomarkers in plasma samples . Anjo et al., (2017) briefly summarized the clinical and fundamental researches based on SWATH-MS, which led to the identification of a number of candidate biomarkers for different diseases . Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.
[232] Mass-spectrometry-based proteomics: from single cells to clinical ... — Mass-spectrometry-based proteomics: from single cells to clinical applications | Nature Mass-spectrometry-based proteomics: from single cells to clinical applications This study introduces DVP, which combines AI-driven image analysis with high-resolution mass spectrometry to map protein expression patterns in specific cell types within complex tissues, enabling exceptional spatial resolution for functional studies in proteomics. We acknowledge the following for financial support: the National Natural Science Foundation of China (Major Research Plan, grant 92259201), the National Key R&D Program of China (grant 2021YFA1301600) and the Westlake Education Foundation (to T.G.); the Max Planck Society for the Advancement of Science (to M.M.); and the National Institutes of Health National Institute on Aging (R01 AG071858), the Rainwater Foundation and the Ellison Foundation (to J.A.S.).
[233] An Introduction to Mass Spectrometry-Based Proteomics — Mass spectrometry is unmatched in its versatility for studying practically any aspect of the proteome. Because the foundations of mass spectrometry-based proteomics are complex and span multiple scientific fields, proteomics can be perceived as having a high barrier to entry. This tutorial is intended to be an accessible illustrated guide to the technical details of a relatively simple
[249] Trends and Advancements in Proteomics | Technology Networks — But MS-based single-cell proteomics is not without its limitations; its sensitivity could still be improved, and throughput is still much lower than scRNA-seq, albeit recent methods have enabled analysis of thousands of single cells per day. In Nature Methods, Mann, alongside Dr. Florian Rosenberger and Dr. Marvin Thielert, argues that, “while most of the building blocks for single-cell proteomics are in place, applications to date have mostly been technological proofs of principle.” In the authors’ opinion, this is largely due to the “limited depth of quantitative depth of coverage achieved so far” and issues relating to throughput. Looking to the future of the proteomics field, a growing area of interest has been building around non-MS-based single molecule protein sequencing approaches, which measure individual copies of peptides.
[253] What Are the Key Challenges in Proteomics Analysis — The vast number of proteins, their diverse post-translational modifications, and complex interactions make it challenging to analyze and interpret proteomic data accurately. By addressing key issues related to sample preparation, data complexity, quantitative proteomics, post-translational modifications, and validation, researchers can enhance the quality and reliability of their proteomics analyses. Post-translational modifications (PTMs) play a crucial role in the field of proteomics, significantly impacting the structure, function, and regulation of proteins. Post-translational modifications (PTMs) play a crucial role in the field of proteomics, significantly impacting the structure, function, and regulation of proteins. Post-translational modifications (PTMs) play a crucial role in the field of proteomics, significantly impacting the structure, function, and regulation of proteins.
[255] Advances, obstacles, and opportunities for machine learning in proteomics — This review focuses on a subset of the machine learning field, supervised classification; its application to proteomics could be described as leveraging generalized mathematical tools that use data from a set of known sample types to make predictions about samples of unknown type. The most common type of machine learning associated with the applications of interest herein, namely, proteomics tools development and biomarker discovery problems, is supervised classification; sometimes an up-front feature selection step is also included. In some types of studies, where proteomics and machine learning are combined, developing the set of known data to train the algorithm is straightforward.
[257] Challenges and Opportunities for Single-cell Computational Proteomics — Mass spectrometry-based proteomics enables high throughput profiling of proteins within a sample and has proved to be ... 82, 83)—and then discuss the challenges for single-cell proteomics. Protein identification algorithms group peptide sequences into a protein. ... Noble W.S. Machine learning strategy that leverages large data sets to
[262] PDF — Another challenge is the dynamic range: proteins can be present at anywhere from ... their potential integration into a ... promise for single-cell proteomics is single- molecule sequencing. One
[263] Cataloguing the proteome: Current developments in single-molecule ... — Challenges for SMPS. While the genomics revolution was made possible in part due to the rapid progress in next-generation DNA sequencing technologies, high-throughput protein sequencing technologies that are both accurate and sensitive lag behind their DNA counterparts. 6 This delay can be attributed to several causes, including the extreme diversity of cellular proteomes compared to the
[264] Challenges and Opportunities in Clinical Applications of Blood-Based ... — However, several challenges need to be met for successful application of serum/plasma based proteomics. These include uniform pre-analyte processing of specimens, sensitive and specific proteomic analytical platforms and adequate attention to study design during discovery phase followed by validation of discovery-level signatures for prognostic